Last update 14 Nov 2024
BD-211
Last update 14 Nov 2024
Overview
Basic Info
Drug Type Gene therapy, Hematopoietic stem cell therapy |
Synonyms BD211自体CD34+造血干细胞注射液, BD 211, BD-211 + [1] |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with BD-211BD211静脉输注治疗输血依赖型β-地中海贫血患者安全性和有效性的I期临床研究
[Translation] Phase I clinical study on the safety and efficacy of intravenous infusion of BD211 in the treatment of patients with transfusion-dependent β-thalassemia
A Phase 1 Clinical Trail of the Safety and Efficacy of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Intravenous Infusion for the Treatment of Transfusion-dependent β-thalassaemia Patients
Safety and Efficacy of Lentiviral Vector Transduction of β-globin Genetically Modified Autologous CD34+ Hematopoietic Stem Cells in Patients With Transfusion-dependent β-thalassemia
100 Clinical Results associated with BD-211
Login to view more data
100 Translational Medicine associated with BD-211
Login to view more data
100 Patents (Medical) associated with BD-211
Login to view more data
100 Deals associated with BD-211
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Transfusion-dependent Beta Thalassemia | Phase 1 | CN | 26 Jan 2024 | |
| Beta-Thalassemia | Phase 1 | CN | 05 Jan 2024 | |
| Transfusion-dependent Thalassemia | Phase 1 | CN | 05 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free